Involvement of the BK channels/G proteins processes in the synergistic effects between anticholinergic agents and beta2 -adrenoceptor agonists in airway smooth muscle Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013
Synergistic effects by combination of tiotropium with olodaterol result from cross talk between muscarinic and β2-adrenergic receptors via allosteric modulation Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016
Endothelin-1-mediated contraction of mouse small airways is resistant to salbutamol, but sensitive to rosiglitazone Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013
Central role of AC6 in β2 agonist induced relaxation of human airway smooth muscle Source: International Congress 2016 – Novel insights into the treatment of COPD Year: 2016
Pharmacological interaction between glycopyrronium bromide and indacaterol fumarate on the human airways tone Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016
Pharmacological characterization of the mechanism of action leading to synergism between glycopyrronium bromide and indacaterol fumarate Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016
Serelaxin is a potent inhibitor of airway contraction and enhances β-adrenoceptor-mediated relaxation Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015
A comparison of beta2 -adrenoceptor desensitisation induced by olodaterol and formoterol in human lung mast cells and airway smooth muscle cells Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013
Interaction between aclidinium bromide and formoterol fumarate; effects on human bronchial smooth muscle Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014
The anti-proliferative effect of hydrogen sulfide upon human airway smooth muscle in COPD Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis Year: 2014
Prostacyclin IP receptor activation blocks hyperosmolar-induced bronchoconstriction in isolated human small airways Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016
Bitter taste receptors are expressed and induce relaxation of human bronchi Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013
Beneficial effects of menthol are mediated via a TRPM8-independent mechanism Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD Year: 2015
Bronchodilator activity of the combination of salbutamol hemisuccinate and methatropium iodide compared with monotherapy in preclinical studies Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015
Abediterol, a novel long-acting inhaled beta2 -agonist, has a fast association rate and long residence time at human beta2 receptors Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014
The effect of adenosine on VEGF release from airway smooth muscle from subjects with asthma Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013
The effect of JQ1/SGCBD01 upon c-Myc in human airway smooth muscle in asthma Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014
Activation of TRPV4 causes bronchoconstriction: A possible role in respiratory disease? Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD Year: 2013
Secretion of hyaluronic acid is mediated by muscarinic receptors in airway smooth muscle cells of patients with COPD Source: International Congress 2014 – Translational studies in COPD Year: 2014
A functional role for WNT-5A in driving airway myocyte proliferation Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013